Small-Molecule Targeting MuRF1 Protects Against Denervation-Induced Diaphragmatic Dysfunction: Underlying Molecular Mechanisms.

<p><b>BACKGROUND</b></p><p>Mechanical inactivity rapidly induces diaphragm muscle fibres' contractile dysfunction and atrophy. Diaphragm weakness can impair respiratory function, quality of life and increase risks of morbidity and mortality.

Muscle RING-finger protein-1 (MuRF1) expression is upregulated during denervation and muscle inactivity and is known to target key muscle proteins for degradation. We previously reported that the small-molecule targeting MuRF1 (MyoMed-205) protects against diaphragm contractile dysfunction and atrophy after 12โ€‰h of unilateral diaphragm denervation (UDD) in rats.

In this study, we investigated the mechanisms by which MyoMed-205 protects the diaphragm structure and function during early UDD in rats.</p><p><b>METHODS</b></p><p>Male Wistar rats were subjected to unilateral diaphragm denervation (UDD) for 12โ€‰h. Immediately after UDD, rats received either a placebo (vehicle) or small-molecule targeting MuRF1 (MyoMed-205, 50โ€‰mg/kg bw), and outcomes were compared with sham-operated controls.

Diaphragm was used for histological, morphometric, transcriptomic (RNA-seq) and protein content (Western blot) analysis.</p><p><b>RESULTS</b></p><p>UDD induced diaphragm slow- (Type I: pโ€‰=โ€‰0.03) and fast-twitch (Type IIa: pโ€‰=โ€‰0.04; Type IIb/x: pโ€‰=โ€‰0.02) fibres atrophy after 12โ€‰h, which was prevented by MyoMed-205 (pโ€‰<โ€‰0.05). Mechanistically, UDD perturbed mechanisms involved with myofibre ultrastructure and contractility, mitochondrial function, proteolysis and tissue remodelling in the diaphragm.

MyoMed-205 enhanced the activation of mechanisms required for sarcomere integrity, calcium handling, antioxidant defence, chaperone-mediated unfolded protein response and muscle growth. MyoMed-205 also mitigated intramuscular fat deposition and pro-fibrotic responses triggered by UDD.</p><p><b>CONCLUSIONS</b></p><p>Small-molecule targeting MuRF1 (MyoMed-205) protects against diaphragm muscle contractile dysfunction and atrophy after 12โ€‰h of UDD.

Herein, we demonstrate that this protective effect involved augmented activation of signalling pathways controlling muscle structure and function, chaperone-mediated unfolded protein and muscle growth, while mitigating intramuscular fat deposition and pro-fibrotic responses triggered by UDD at the transcriptional and/or protein level.</p>

Subscribe to the SCWD Newsletter

Stay Informed with the Latest Updates and Exclusive Insights!